Clinical Trials
20 trialsNCT07610525 2026-05-28
Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT05294900 2026-05-26
NEOS
Yonsei University
Phase 2 Completed
NCT04016142 2026-03-18
ACCRAPAN
Centre Oscar Lambret
Phase 2 Terminated
NCT07102940 2026-02-20
Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer
George Washington University
Phase 2 Not yet recruiting
NCT07401654 2026-02-10
The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Not yet recruiting
NCT06353906 2025-12-08
PRIAM
The Netherlands Cancer Institute
Phase 2 Recruiting
NCT07107217 2025-08-17
Camella
Blokhin's Russian Cancer Research Center
Phase 2 Not yet recruiting
NCT06713057 2024-12-03
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
West China Hospital
Phase 2 Not yet recruiting
NCT04807166 2024-07-03
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Active not recruiting
NCT01367002 2023-05-17
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Yale University
Phase 2 Completed
NCT04982549 2021-08-06
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT00584857 2017-01-27
A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT00919880 2014-08-15
Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer
Peking University
Phase 2 Completed
NCT01872403 2013-06-07
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage â…¡ B and IIIA Squamous Cell Carcinoma of the Lung
The First Affiliated Hospital of Guangzhou Medical University
Phase 2 Unknown
NCT01196234 2013-01-29
PRIDE
Asan Medical Center
Phase 2 Completed
NCT00340184 2010-10-19
A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients
Korean Gynecologic Oncology Group
Phase 2 Completed
NCT01203267 2010-09-16
Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2 Completed
NCT01158144 2010-07-08
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT00894569 2009-05-14
PACET-CUP
Heidelberg University
Phase 2 Unknown
NCT00259675 2007-11-15
Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC
University of Saskatchewan
Phase 2 Completed